Aurélien Gobert

1.8k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Aurélien Gobert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Aurélien Gobert has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Aurélien Gobert's work include Viral-associated cancers and disorders (6 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Aurélien Gobert is often cited by papers focused on Viral-associated cancers and disorders (6 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Aurélien Gobert collaborates with scholars based in France, United States and Belgium. Aurélien Gobert's co-authors include Jean‐Philippe Spano, Douglas B. Johnson, Joe‐Elie Salem, Ali Manouchehri, Melissa Moey, Javid J. Moslehi, Dan M. Roden, Bénédicte Lebrun‐Vignes, Justin M. Balko and Lisa Bastarache and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Aurélien Gobert

16 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

2018 836 citations Joe‐Elie Salem, Ali Manouchehri et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aurélien Gobert France	8	869	416	301	235	143	20	1.2k
Ali Manouchehri United States	7	978 1.1×	287 0.7×	415 1.4×	197 0.8×	81 0.6×	13	1.5k
Douglas B. Johnson United States	8	1.1k 1.3×	235 0.6×	536 1.8×	160 0.7×	124 0.9×	10	1.5k
Darrin Despain United States	14	322 0.4×	704 1.7×	322 1.1×	172 0.7×	157 1.1×	28	1.5k
Jey-Hsin Chen United States	6	481 0.6×	256 0.6×	498 1.7×	269 1.1×	104 0.7×	11	1.1k
Abdul Rafeh Naqash United States	18	1.3k 1.4×	479 1.2×	67 0.2×	224 1.0×	94 0.7×	103	1.5k
José Maria Augé Spain	18	374 0.4×	295 0.7×	318 1.1×	263 1.1×	405 2.8×	25	1.3k
Tsukasa Hotta Japan	18	544 0.6×	252 0.6×	67 0.2×	226 1.0×	438 3.1×	85	1.0k
Ηλίας Κοττέας Greece	18	570 0.7×	330 0.8×	47 0.2×	319 1.4×	74 0.5×	76	1.1k
Elizabeth Dudnik Israel	19	817 0.9×	717 1.7×	94 0.3×	221 0.9×	74 0.5×	69	1.2k
Teresa M. Petrella Canada	19	973 1.1×	162 0.4×	107 0.4×	390 1.7×	103 0.7×	62	1.3k

Countries citing papers authored by Aurélien Gobert

Since Specialization

Citations

This map shows the geographic impact of Aurélien Gobert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Gobert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Gobert more than expected).

Fields of papers citing papers by Aurélien Gobert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélien Gobert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Gobert. The network helps show where Aurélien Gobert may publish in the future.

Co-authorship network of co-authors of Aurélien Gobert

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélien Gobert. A scholar is included among the top collaborators of Aurélien Gobert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélien Gobert. Aurélien Gobert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oudard, Stéphane, Marc‐Olivier Timsit, Denis Maillet, et al.. (2024). Cancer de prostate métastatique résistant à la castration et inhibiteurs de PARP : de la génomique tumorale aux nouvelles associations thérapeutiques. Bulletin du Cancer. 112(1). 61–81.

Barthélémy, Philippe, Yohann Loriot, Constance Thibault, et al.. (2024). Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.. Journal of Clinical Oncology. 42(4_suppl). 561–561. 13 indexed citations

Bylicki, Olivier, Florian Guisier, Catherine Daniel, et al.. (2023). Real-life efficacy of nivolumab plus ipilimumab combination in untreated, unresectable malignant pleural mesotheliomas: Result of French early access program—MESOIMMUNE – GFPC 04-2021.. Journal of Clinical Oncology. 41(16_suppl). 8536–8536.

Barthélémy, Philippe, Constance Thibault, Delphine Borchiellini, et al.. (2021). Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data. Cancer Treatment Reviews. 97. 102191–102191. 19 indexed citations

Drouin, Sarah, Pietro Grande, Christophe Vaessen, et al.. (2020). Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre study. Urologic Oncology Seminars and Original Investigations. 38(6). 599.e15–599.e21. 7 indexed citations

Grande, Pietro, Thomas Seisen, Aurélien Gobert, et al.. (2019). Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study. World Journal of Urology. 37(8). 1491–1498. 4 indexed citations

Campi, Riccardo, Juliette Cotte, Francesco Sessa, et al.. (2019). Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience. World Journal of Urology. 37(11). 2303–2311. 30 indexed citations

Lucidarme, Olivier, Mathilde Wagner, Paul Gillard, et al.. (2019). RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study. Cancer Imaging. 19(1). 85–85. 9 indexed citations

Spano, Jean‐Philippe, Marianne Veyri, Aurélien Gobert, et al.. (2019). Immunotherapy for cancer in people living with HIV. AIDS. 33(11). F13–F19. 49 indexed citations

10.

Bertolus, Chloé, et al.. (2019). Efficacy and prognostic factors of systemic therapies for metastatic adenoid cystic carcinoma.. Journal of Clinical Oncology. 37(15_suppl). e17587–e17587.

11.

Quéro, L., Aurélien Gobert, & Jean‐Philippe Spano. (2018). Spécificités de la prise en charge par radiothérapie chez les patients séropositifs pour le virus de l’immunodéficience humaine (VIH). Cancer/Radiothérapie. 22(6-7). 496–501.

12.

Salem, Joe‐Elie, Ali Manouchehri, Melissa Moey, et al.. (2018). Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. The Lancet Oncology. 19(12). 1579–1589. 836 indexed citations breakdown →

13.

Gobert, Aurélien, Marianne Veyri, Isabelle Poizot‐Martin, et al.. (2018). Cancer et VIH : actualités 2017. Bulletin du Cancer. 105(3). 256–262. 2 indexed citations

14.

Tardy, Magalie P., R. Delva, Pernelle Lavaud, et al.. (2018). Neuroendocrine carcinoma of the urinary bladder: A large analysis of the French GETUG consortium. Annals of Oncology. 29. viii321–viii322. 1 indexed citations

15.

Grande, Pietro, et al.. (2018). Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes. British Journal of Urology. 123(4). 618–623. 5 indexed citations

16.

Gobert, Aurélien, Marianne Veyri, A. Lavolé, et al.. (2018). Tolerance and efficacy of immune-checkpoint inhibitors for cancer in people living with HIV (PWHIV). Annals of Oncology. 29. viii733–viii733. 3 indexed citations

17.

Planchard, David, Yohann Loriot, Fabrice André, et al.. (2015). EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients. Annals of Oncology. 26(10). 2073–2078. 255 indexed citations

18.

Gobert, Aurélien, et al.. (2015). Cancer and Immune Suppression: from Epidemiology to Therapeutic Challenges. 1 indexed citations

19.

Gobert, Aurélien & Jean‐Philippe Spano. (2015). Cancer et immunodépression : de l’épidémiologie à la thérapeutique. ONCOLOGIE. 17(9). 390–396. 1 indexed citations

20.

Gobert, Aurélien, Nicolas Mounier, A. Lavolé, Isabelle Poizot‐Martin, & Jean‐Philippe Spano. (2014). VIH et Cancer: état Des Connaissances. Bulletin du Cancer. 101(11). 1020–1029. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact